Changeflow GovPing Pharma & Drug Safety Yellowbird Diagnostics Intent to Use Trademark ...
Routine Notice Added Final

Yellowbird Diagnostics Intent to Use Trademark Application

Favicon for changeflow.com ChangeBridge: Trademarks - Pharmaceuticals (Class 005)
Published November 12th, 2025
Detected March 24th, 2026
Email

Summary

The USPTO has received an intent-to-use trademark application from Yellowbird Diagnostics for goods and services related to diagnostic reagents, contrast media, and radiopharmaceuticals. The application was filed on November 12, 2025, with an expected use date of March 22, 2026.

What changed

This document is an intent-to-use trademark application filed with the USPTO by Yellowbird Diagnostics. The application, TM99492792, covers a range of products including clinical diagnostic reagents, contrast media for medical imaging, radiopharmaceutical agents for cancer detection, and surgical dyes. The filing date was November 12, 2025, and the applicant has indicated an intent to use the mark by March 22, 2026.

This filing signifies Yellowbird Diagnostics' intention to establish a trademark for its pharmaceutical and diagnostic products. While this is not a regulatory rule or enforcement action, it is a key step in brand protection for companies operating in the pharmaceutical and medical device sectors. Compliance officers should note this filing as it pertains to the commercialization strategy of a company in this space.

Source document (simplified)

← USPTO Trademark Applications

YELLOWBIRD DIAGNOSTICS

Intent to Use TM99492792 Kind: intenttouse Mar 22, 2026

Abstract

clinical diagnostic reagents; contrast media for in vivo imaging; contrast media for use with medical imaging equipment; diagnostic agents for medical use in in vivo scanning; imaging agents for magnetic resonance imaging (MRI); medical imaging contrast media; radio-isotope markers for diagnostic use; radiopharmaceutical agents for use in amyloid pathology detection; radiopharmaceutical imaging and detection agents for diagnosing andmonitoring cancer; radiopharmaceutical preparations for diagnostic purposes; radiopharmaceuticals; surgical dyes; active chemical ingredients for use in the manufacture of pharmaceuticals; carbohydrates used as an ingredient in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the production of medicines

Filing Date

2025-11-12

View original document →

Classification

Agency
USPTO
Published
November 12th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99492792

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Trademarks Medical Devices

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.